Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
Conditions: Healthy Interventions: Behavioral: Group 1 (I x S x S x F); Behavioral: Group 2 (O x S x S x F); Behavioral: Group 3 (I x E x S x F); Behavioral: Group 4 (O x E x S x F); Behavioral: Group 5 (I x S x S x M); Behavioral: Group 6 (O x S x S x M); Behavioral: Group 7 (I x E x S x M); Behavioral: Group 8 (O x E x S x M); Behavioral: Group 9 (I x S x D x F); Behavioral: Group 10 (O x S x D x F); Behavioral: Group 11 (I x E x D x F); Behavioral: Group 12 (O x E x D x F); Behavioral: Group 13 (I x S x D x M); Behavioral: Group 14 (O x S x D x M); Behavioral: Group 15 (I x E x D x M); Behavioral: Group 16 (O x E x D x ...
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC ®) in Women Living With HIV Aged 15-25 Years
Conditions: Human Papillomavirus Infection Interventions: Biological: Cervavac as three dose regimen; Biological: Cervavac as two dose regimen; Biological: Gardasil as three dose regimen Sponsors: Serum Institute of India Pvt. Ltd.; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Conditions: Human Papilloma Virus Interventions: Biological: Gardasil 9 Sponsors: University of Alabama at Birmingham; Merck Investigator Studies Program Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine
Conditions: Human Papillomavirus Infection Interventions: Biological: Nonavalent HPV study vaccine; Biological: GARDASIL ® 9 Sponsors: Beijing Health Guard Biotechnology, Inc; University of Muhammadiyah Malang Hospital; Dr. M Djamil Hospital, Padang Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2024 Category: Research Source Type: clinical trials
A Phase III Trial to Evaluate the Immunogenicity and Safety of HPV Vaccine
Conditions: Human Papillomavirus Infection Interventions: Biological: nonavalent HPV study vaccine; Biological: GARDASIL ® 9 Sponsors: Beijing Health Guard Biotechnology, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil ®9 in Young Women
Conditions: Cervical Cancer; Condylomata Acuminata Interventions: Biological: Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli); Biological: Gardasil ®9 Sponsors: Xiamen Ophthalmology Center Affiliated to Xiamen University; Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease
Conditions: Human Papillomavirus Vaccine; Chronic Condition Interventions: Other: Questionnaire Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
Conditions: Vaccine Reaction Interventions: Drug: Gardasil; Drug: Gardasil; Drug: Gardasil; Device: PharmaJet Stratis ® Needle-Free Injection System; Device: PharmaJet Tropis® Needle-Free Injection System Sponsors: PharmaJet, Inc.; National Institutes of Health (NIH); National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL
Conditions: Vulvar HSIL; HPV Interventions: Drug: Gardasil 9 Suspension for Injection; Drug: Placebo Sponsors: Erasmus Medical Center; Dutch Cancer Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts
Conditions: Human Papilloma Virus; Anogenital Wart Intervention: Biological: the Quadrivalent Vaccine (Gardasil) Sponsor: Zagazig University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials
